Biopharmaceuticals Startups That Raised Funding in Australia

Paradigm Biopharmaceuticals

Location: Sydney, Australia

Funding: raises $14M

Date: 60 days ago

Paradigm Biopharmaceuticals is an ASX-listed biopharmaceutical company developing regenerative therapies for osteoarthritis and other musculoskeletal conditions. Its proprietary small-molecule treatments aim to stimulate cartilage repair and bone regeneration to address degenerative joint disease and associated pain.

Zelira Therapeutics

Location: Australia

Website: zeliratx.com

Funding: secures transformative US$33 m

Date: 161 days ago

Zelira Therapeutics is an ASX­-listed Australian biopharmaceutical company specializing in cannabis­-based and psychedelic-derived therapeutics, advancing clinical programs such as its HOPE­-1 autism treatment.

ENA Respiratory

Location: Australia

Funding: Secures AU$34M

Date: 242 days ago

ENA Respiratory is a clinical-stage biopharmaceutical company developing antiviral drugs that enhance the body's natural defense against respiratory viruses to reduce the severity of symptomatic infections.

Tryptamine

Location: Australia

Funding: secures $2.6 m

Date: 318 days ago

Tryptamine is an Australian clinical-stage biopharmaceutical company developing psilocin-based psychedelic therapies for neurological and psychiatric disorders.